Clinical Trial Update: Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature Infants [Phase 4]

View source ↗

Summary

Phase 4 trial in premature infants evaluating cytokine changes in bronchoalveolar lavage fluid after early budesonide-surfactant treatment; the study was termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Respiratory Distress Syndrome

Drugs mentioned

• Budesonide (BUDESONIDE)
• Exogenous Surfactant (surfactant)

Snippet

Sponsor: China Medical University Hospital | Conditions: Premature Infants, Respiratory Distress Syndrome | Phase 4 | Status: TERMINATED